Vindesine
| |
| |
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 65-75% |
Metabolism | Hepatic (CYP3A4-mediated) |
Elimination half-life | 24 hours |
Excretion | Biliary and renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard |
100.053.330 |
Chemical and physical data | |
Formula | C43H55N5O7 |
Molar mass | 753.926 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
Vindesine is an anti-mitotic vinca alkaloid used in chemotherapy. It is used to treat many different types of cancer, including leukaemia, lymphoma, melanoma, breast cancer, and lung cancer.
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.